Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Not all vaping is the same: differential pulmonary effects of vaping cannabidiol versus nicotine
Tariq A. Bhat, Suresh Kalathil, Maciej Ł. Goniewicz, et al.
Thorax (2023) Vol. 78, Iss. 9, pp. 922-932
Open Access | Times Cited: 23

Showing 23 citing articles:

Current Challenges and Opportunities for Improved Cannabidiol Solubility
Khondker R. Hossain, Amani Alghalayini, Stella M. Valenzuela
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14514-14514
Open Access | Times Cited: 22
The Association Between Past 12-Month Synthetic Cannabinoid Polysubstance Use and Cannabis Use Disorder in a Nationally Representative US Sample
Weisiyu Qin, Dong‐Chul Seo, Shin Hyung Lee, et al.
International Journal of Mental Health and Addiction (2025)
Closed Access
The relationship between cannabis and cardiovascular disease: clearing the haze
Mark Chandy, Nerea Jimenez-Tellez, Joseph C. Wu
Nature Reviews Cardiology (2025)
Closed Access
Cannabis consumption and risk of asthma: a systematic review and meta-analysis
Ajay Malvi, Mahalaqua Nazli Khatib, Ashok Kumar Balaraman, et al.
BMC Pulmonary Medicine (2025) Vol. 25, Iss. 1
Open Access
Prevalence and Factors Associated With Vaping Cannabidiol Among US Adolescents
Hongying Dai, Roma Subramanian, Avina Mahroke, et al.
JAMA Network Open (2023) Vol. 6, Iss. 8, pp. e2329167-e2329167
Open Access | Times Cited: 9
Challenges in current inhalable tobacco toxicity assessment models: A narrative review
Thivanka Muthumalage, Alexandra Noël, Yasmin Thanavala, et al.
Tobacco Induced Diseases (2024) Vol. 22, Iss. June, pp. 1-17
Open Access | Times Cited: 2
Childhood exposure to cannabidiol and lung function: A pilot study
Nolan Younoszai, Christopher Hollander, Gregory L. Kinney, et al.
Pediatric Pulmonology (2024) Vol. 59, Iss. 12, pp. 3766-3769
Open Access | Times Cited: 2
Time to be blunt: Substance use in cystic fibrosis
Sanaz Vaziri, Meghan E. McGarry, Chiung‐Yu Huang, et al.
Pediatric Pulmonology (2024) Vol. 59, Iss. 4, pp. 1015-1027
Open Access | Times Cited: 1
Association of vaping with respiratory symptoms in U.S. young adults: Nicotine, cannabis, and dual vaping
Ruoyan Sun, Gabriela R. Oates
Preventive Medicine (2024) Vol. 189, pp. 108175-108175
Closed Access | Times Cited: 1
Cannabidiol - Help and hype in targeting mucosal diseases
Md. Moniruzzaman, Taskeen Iqbal Janjua, Jennifer Martin, et al.
Journal of Controlled Release (2023) Vol. 365, pp. 530-543
Open Access | Times Cited: 4
Do alternative tobacco products induce less adverse respiratory risk than cigarettes?
Tariq A. Bhat, Suresh Kalathil, Noel J. Leigh, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 3
The prostaglandin D2 antagonist asapiprant ameliorates clinical severity in young hosts infected with invasive Streptococcus pneumoniae
Manmeet Bhalla, Sydney E. Herring, Alexsandra Lenhard, et al.
Infection and Immunity (2024) Vol. 92, Iss. 5
Closed Access
Exploring the Interplay Between Cannabinoids and Thymic Functions
Marvin Paulo Lins, Igor Santana de Melo
Toxicological Sciences (2024)
Closed Access
An examination of the methods and variables used in experimental design that impact the toxicological outcomes of e-cigarettes
Jon Beard, Christie M. Sayes
Food and Chemical Toxicology (2024) Vol. 193, pp. 114999-114999
Closed Access
Can switching from cigarettes to heated tobacco products reduce consequences of pulmonary infection?
Tariq A. Bhat, Suresh Kalathil, Noel J. Leigh, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access
Assessing the Association between Respiratory Symptoms, Nicotine and Cannabis Use via Traditional and E-product Devices in the United States
Philip Veliz, John Jardine, Luisa Kcomt, et al.
AJPM Focus (2024) Vol. 4, Iss. 1, pp. 100291-100291
Open Access
Chemical Composition of Aerosols from the E-Cigarette Vaping of Natural and Synthetic Cannabinoids
Nicholas E. Robertson, Jack A. Connolly, Nikolay E. Shevchenko, et al.
Chemical Research in Toxicology (2024)
Closed Access
Oxidized phospholipid and transcriptomic signatures of THC-related vaping associated lung injury
Tomeka Suber, Mohammadreza Tabary, William Bain, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Informing the Cannabis Conjecture: From Life’s Beginnings to Mitochondria, Membranes and the Electrome—A Review
Alistair V.W. Nunn, Geoffrey W. Guy, Jimmy D. Bell
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13070-13070
Open Access | Times Cited: 1
Vaping and CBD: can new technology overcome old problems?
Aaron Scott
Thorax (2023) Vol. 78, Iss. 9, pp. 845-847
Closed Access
(V)aperçu on the harm of nicotine e-cigarettes
Wolfgang M. Kuebler
European Respiratory Journal (2023) Vol. 61, Iss. 6, pp. 2300886-2300886
Closed Access
Time To Be Blunt: Substance Use In Cystic Fibrosis
Sanaz Vaziri, Meghan E. McGarry, Chiung‐Yu Huang, et al.
Authorea (Authorea) (2023)
Open Access
Recency of Cannabis Vaping in Sexual Minorities in Wave 5 of the Population Assessment of Tobacco and Health (PATH) Study
Dale Dagar Maglalang, Yuanyuan Hu, Daniel Baslock, et al.
Substance Use & Misuse (2023) Vol. 59, Iss. 1, pp. 136-142
Closed Access
Page 1

Scroll to top